🔗 Permalink

Inventor profile of:

Rita Dost

City:

Dresden

Country:

Germany

Published Applications:

11

Last publication date:

2018-10-04

Top Assignees for applications by Rita Dost

The entities that hold a legal rights for patent applications filed by inventor Dost Rita:

BOEHRINGER INGELHEIM VETMEDICA GMBH 3 Ingelheim, Germany
JANSSEN PHARMACEUTICALS, INC. 3 Titusville, NJ United States
BOEHRINGER INGELHEIM INTERNATIONAL GMBH 1 Ingelheim, Germany

Recent patent applications by Dost Rita

Rita Dost from Dresden, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2018-10-04

US20180282305A1

Chemistry; metallurgy

Triazoles as NR2B receptor inhibitors

#2 | 2017-09-28

US20170275254A1

Chemistry; metallurgy

Pyrazoles

#3 | 2017-08-10

US20170226087A1

Chemistry; metallurgy

Triazoles as NR2B receptor inhibitors

#4 | 2016-12-22

US20160367562A1

Human necessities

USE OF DIHYDROIMIDAZOLONES FOR THE TREATMENT OF DOGS

#5 | 2015-03-12

US20150072983A1

Chemistry; metallurgy

Use of dihydroimidazolones for the treatment of dogs

#6 | 2013-03-14

US20130065898A1

Human necessities

Use of dihydroimidazolones for the treatment of dogs

#7 | 2012-11-29

US20120302564A1

Chemistry; metallurgy

(1,2,4)triazolo[4,3-A]quinoxaline derivatives as inhibitors of phosphodiesterases

#8 | 2008-05-15

US20080114032A1

Human necessities

Method of treating or preventing central nervous system disorders with compounds having selectivity for the alpha 3 subunit of the benzodiazepine receptor

#9 | 2008-01-31

US20080027057A1

Human necessities

Use of dihydroimidazolones for the treatment of dogs

#10 | 2005-03-31

US20050070537A1

Human necessities

Use of dihydroimidazolones for the treatment of dogs

#11 | 2005-02-10

US20050032863A1

Human necessities

Method of treating or preventing central nervous system disorders with compounds having selectivity for the alpha 3 subunit of the benzodiazepine receptor

InventorID:

141063 ⎘